國家衛生研究院 NHRI:Item 3990099045/2072

NHRI > National Institute of Infectious Diseases and Vaccinology > Hsiu-Jung Lo > Periodical Articles > Item 3990099045/2072

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/2072

Title:	Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species
Authors:	Cheng, MF;Yang, YL;Yao, TJ;Lin, CY;Liu, JS;Tang, RB;Yu, KW;Fan, YH;Hsieh, KS;Ho, M;Lo, HJ
Contributors:	Division of Clinical Research;Division of Biostatistics and Bioinformatics
Abstract:	Background: Invasive fungal infections, such as candidemia, caused by Candida species have been increasing. Candidemia is not only associated with a high mortality (30% to 40%) but also extends the length of hospital stay and increases the costs of medical care. Sepsis caused by Candida species is clinically indistinguishable from bacterial infections. Although, the clinical presentations of the patients with candidemia caused by Candida albicans and non-albicans Candida species (NAC) are indistinguishable, the susceptibilities to antifungal agents of these species are different. In this study, we attempted to identify the risk factors for candidemia caused by C. albicans and NAC in the hope that this may guide initial empiric therapy. Methods: A retrospective chart review was conducted during 1996 to 1999 at the Veterans General Hospital-Taipei. Results: There were 130 fatal cases of candidemia, including 68 patients with C. albicans and 62 with NAC. Candidemia was the most likely cause of death in 55 of the 130 patients (42.3%). There was no significant difference in the distribution of Candida species between those died of candidemia and those died of underlying conditions. Patients who had one of the following conditions were more likely to have C. albicans, age &GE; 65 years, immunosuppression accounted to prior use of steroids, leukocytosis, in the intensive care unit (ICU), and intravascular and urinary catheters. Patients who had undergone cancer chemotherapy often appeared less critically ill and were more likely to have NAC. Conclusion: Clinical and epidemiological differences in the risk factors between candidemia caused by C. albicans and NAC may provide helpful clues to initiate empiric therapy for patients infected with C. albicans versus NAC.
Keywords:	Infectious Diseases
Date:	2005-04-07
Relation:	BMC Infectious Diseases. 2005 Apr;5:Article number 22.
Link to:	http://dx.doi.org/10.1186/1471-2334-5-22
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1471-2334&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000228927000001
Cited Times(Scopus):	http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=25444434148
Appears in Collections:	[Hsiu-Jung Lo] Periodical Articles [Chin-Yu Lin(2002-2003)] Periodical Articles [Monto Ho(1997-2002)] Periodical Articles [Tzu-Chun Yao(1999-2002)] Periodical Articles

Files in This Item:

File	Description	Size	Format
000228927000001.pdf		236Kb	Adobe PDF	1022	View/Open

Loading...